It is a healthcare private limited company based in Nehru Place, Delhi, India, established in 2020.
2020 | Nehru Place, Delhi, India | ActiveByrl Bioceuticals India Private Limited, a active private limited company, was established on 13 August 2020 in Nehru Place, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U15400DL2020PTC367927. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
Formerly known as Neuhope Bioceuticals Private Limited. Its leadership includes Akanksha Jain (Additional Director), Ankur Goyal (Additional Director), Priyata Goyal (Director). Past directors included Sonika Verma, Priyanka Srivastava. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 702, 7Th Floor Madhuban Building 55, Nehru Place, Delhi, 110019.
U15400DL2020PTC367927
367927
13 August 2020
₹1.00 M
₹0.15 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Byrl Bioceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akanksha Jain | Additional Director | 02 Jun 2021 | Current |
| Ankur Goyal | Additional Director | 15 Jun 2022 | Current |
| Priyata Goyal | Director | 13 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jun 2021 | Past |
| Pramod Abcsdd | Director | 02 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Byrl Bioceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1142.72% increase. The company also saw a substantial fall in profitability, with a 356.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 9440.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Byrl Bioceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Byrl Bioceuticals India has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Byrl Bioceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Byrl Bioceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Byrl Bioceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Byrl Bioceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.
The activity Ankur Goyal was appointed as a Additional Director was appointed as a Additional Director on 15 Jun 2022 & has been associated with this company since 3 years 5 months . was completed.
Progress on Akanksha Jain was appointed as a Additional Director was appointed as a Additional Director on 02 Jun 2021 & has been associated with this company since 4 years 6 months . was documented.
Progress on Priyata Goyal was appointed as a Director was appointed as a Director on 13 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
Progress on Byrl Bioceuticals India Private Limited was registered on 13 Aug 2020 with Roc Delhi & aged 5 years 3 months as per MCA records. was documented.
The CIN of Byrl Bioceuticals India Private Limited is U15400DL2020PTC367927.
Byrl Bioceuticals India Private Limited is headquartered at 702, 7Th Floor Madhuban Building 55, Nehru Place, Delhi, 110019.
Byrl Bioceuticals India Private Limited was incorporated on 13 August 2020.
The current directors of Byrl Bioceuticals India Private Limited are
The primary industry of Byrl Bioceuticals India Private Limited is Trade.
Byrl Bioceuticals India Private Limited is unlisted.
The authorized capital of Byrl Bioceuticals India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX